Proactive surveillance for Li-Fraumeni syndrome is associated with better survival outcomes and nearly nine-fold lower healthcare costs than treating cancer after diagnosis. The post Proactive Surveillance Pays Off for Patients with Li-Fraumeni Syndrome appeared first on Inside Precision Medicine .